Now millions of people take drugs known as antiretrovirals that keep HIV from spreading in the body. Stopping those drugs lets the virus start multiplying in the body again, and it could become ...
HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
A new formulation of Gilead's HIV prevention drug, lenacapavir, has shown promise in providing yearlong protection with just one injection. The study, published in The Lancet, evaluated the ...
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results